ai foundation model
Longevity Science vs Insilico AI: Who Cuts Trial Timelines?
A new AI foundation model can halve the time to first-in-human trials for Alzheimer’s therapies, cutting the usual 24-month preclinical phase to about 12 months. By pulling together billions of multi-omics data points, the model delivers insights in days instead of months, giving researchers a clear route to faster,